Android app on Google Play

Hologic (HOLX) Wins Appeal on Patent Validity for SenoRx Case; Invalid Ruling Reversed

February 24, 2011 11:17 AM EST Send to a Friend
Bloomberg reporting that Hologic (Nasdaq: HOLX) has won an appeal on patent validity in its SenoRx case.

You May Also Be Interested In

Related Categories


Add Your Comment